Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma – New England Journal of Medicine (link to abstract – $ for full-text)   Commentaries on Twitter Visual Abstract: Efficacy and Safety of Itepekimab for Moderate-to-Severe Asthma https://t.co/7mldcsSaeW pic.twitter.com/RlvE2Z1Tas — NEJM (@NEJM) November 3, 2021 In this randomized trial, the monoclonal antibody itepekimab against interleukin-33 […]

The post Phase II RCT: Efficacy and safety of Itepekimab in patients with moderate-to-severe asthma. appeared first on Links Medicus.